Current Environment: Production

Medical Services

Programs & Services

Languages

  • Chinese (Mandarin)
  • English

Education

Undergraduate School

University of Michigan

1996, Ann Arbor, MI

Medical School

University of Michigan

1999, Ann Arbor, MI

Internship

University of Minnesota Medical School

2000, Minneapolis, MN

Residency

University of Minnesota Medical School

2003, Minneapolis, MN

Fellowship

Cardiovascular Medicine (Adult)

University of Minnesota Medical School

2006, Minneapolis, MN

Fellowship

Boston Children's Hospital

2007, Boston, MA

Certifications

  • American Board of Internal Medicine (Cardiovascular Disease)
  • American Board of Internal Medicine (General)

Professional History

Dr. Wu is board certified in pediatrics, internal medicine, and cardiovascular disease. After receiving his Doctor of Medicine degree from the University of Michigan Medical School in Ann Arbor, he completed a combined residency program in pediatrics and internal medicine at the University of Minnesota Medical Center and a fellowship in cardiovascular disease, also at the University of Minnesota. In 2007, he completed an advanced fellowship in adult congenital heart disease and pulmonary hypertension at Harvard Medical School and stayed on to become a faculty member of the Boston Adult Congenital Heart and Pulmonary Hypertension Program.

Dr. Wu has received a Sanofi-Aventis Fellow Travel Award for research, a teaching award from the Harvard Medical School Academy Center for Teaching and Learning Excellence, and grant funding through Boston Children’s Hospital’s Innovation & Digital Health Accelerator for research into innovative approaches to the management of patients with single ventricle physiology.

Media

Cardiac Conversations

Listen to our experts as they discuss caring for the adult congenital heart.

Publications

  1. Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation. JACC Adv. 2025 Apr; 4(4):101646. View Abstract

  2. Acute Effects of Enhanced External Counterpulsation in Adults With Fontan Circulation. JACC Adv. 2025 Mar; 4(3):101591. View Abstract

  3. Electrocardiographic Changes in Pregnant Patients With Congenital Heart Disease Ann Noninvasive Electrocardiol. 2025 01; 30(1):e70037. View Abstract

  4. Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. Eur Heart J. 2024 Apr 21; 45(16):1477-1480. View Abstract

  5. Dyslipidemia Among Adults With Congenital Heart Disease. JACC Adv. 2022 Oct; 1(4):100081. View Abstract

  6. Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease. JACC Adv. 2022 Mar; 1(1):100008. View Abstract

  7. Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease. JACC Advances. 2022; 1(1):1-11. View Abstract

  8. Associations Between Clinical Outcomes and a Recently Proposed Adult Congenital Heart Disease Anatomic and Physiological Classification System. J Am Heart Assoc. 2021 09 21; 10(18):e021345. View Abstract

  9. Timing of Delivery in Women with Cardiac Disease. Am J Perinatol. 2022 08; 39(11):1196-1203. View Abstract

  10. Intraperitoneal corticosteroids for recurrent ascites in patients with Fontan circulation: Initial clinical experience. J Card Surg. 2021 Feb; 36(2):735-738. View Abstract

  11. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart. 2021 01; 107(1):61-66. View Abstract

  12. Assessment and management of heart failure in the systemic right ventricle. Heart Fail Rev. 2020 07; 25(4):609-621. View Abstract

  13. Surveillance and screening practices of New England congenital cardiologists for patients after the Fontan operation. Congenit Heart Dis. 2019 Nov; 14(6):1013-1023. View Abstract

  14. Fontan Liver Lesions: Not Always HCC. JACC Case Rep. 2019 Aug; 1(2):175-178. View Abstract

  15. Hemodynamic Effects of Paracentesis in a Patient With a Fontan Circulation. World J Pediatr Congenit Heart Surg. 2019 05; 10(3):357-359. View Abstract

  16. Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank). Am J Cardiol. 2018 11 01; 122(9):1557-1564. View Abstract

  17. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469. View Abstract

  18. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 14; 136(20):e348-e392. View Abstract

  19. Liver health in adults with Fontan circulation: A multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017 03; 153(3):656-664. View Abstract

  20. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J Heart Lung Transplant. 2017 Feb; 36(2):211-219. View Abstract

  21. Clinical Approaches to the Patient with a Failing Fontan Procedure. Curr Cardiol Rep. 2016 May; 18(5):44. View Abstract

  22. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc. 2016 Jan 11; 5(1). View Abstract

  23. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View Abstract

  24. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J Clin Endocrinol Metab. 2015 Apr; 100(4):1325-34. View Abstract

  25. Exercise oscillatory ventilation in patients with Fontan physiology. Circ Heart Fail. 2015 Mar; 8(2):304-11. View Abstract

  26. Rare case of undiagnosed supracardiac total anomalous pulmonary venous return in an adult. Circulation. 2014 Sep 30; 130(14):1205-7. View Abstract

  27. Inadequate venous return as a primary cause for Fontan circulatory limitation. J Heart Lung Transplant. 2014 Nov; 33(11):1194-6. View Abstract

  28. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014 Jul 01; 307(1):H110-7. View Abstract

  29. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View Abstract

  30. Outcomes of adolescents and adults undergoing primary Fontan procedure. Am J Cardiol. 2013 Dec 15; 112(12):1938-42. View Abstract

  31. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013 Apr; 99(7):491-6. View Abstract

  32. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013 Sep 01; 167(5):1918-23. View Abstract

  33. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011 May-Jun; 6(3):190-201. View Abstract

  34. Images in clinical medicine. Colonic saccular diverticula. N Engl J Med. 2008 Sep 18; 359(12):e13. View Abstract

  35. Extrapericardial cardiac compression syndrome. Int J Cardiol. 2006 Nov 10; 113(2):285-7. View Abstract

I feel that to serve as a physician is a unique privilege. As adult congenital heart disease specialists, we have the opportunity to care for and to form relationships with our patients through their entire lives. I believe strongly in the model of patients being active partners in their own care. My goal is to treat all individuals with respect and dignity, to maintain a high level of communication and transparency with patients and the rest of their health care team, and to empower everyone to actively participate in care and decision-making.

BESbswy